These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30735597)

  • 1. A Photoswitchable Agonist for the Histamine H
    Hauwert NJ; Mocking TAM; Da Costa Pereira D; Lion K; Huppelschoten Y; Vischer HF; De Esch IJP; Wijtmans M; Leurs R
    Angew Chem Int Ed Engl; 2019 Mar; 58(14):4531-4535. PubMed ID: 30735597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covalent Inhibition of the Histamine H
    Wágner G; Mocking TAM; Kooistra AJ; Slynko I; Ábrányi-Balogh P; Keserű GM; Wijtmans M; Vischer HF; de Esch IJP; Leurs R
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31835873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Characterization of a Bidirectional Photoswitchable Antagonist Toolbox for Real-Time GPCR Photopharmacology.
    Hauwert NJ; Mocking TAM; Da Costa Pereira D; Kooistra AJ; Wijnen LM; Vreeker GCM; Verweij EWE; De Boer AH; Smit MJ; De Graaf C; Vischer HF; de Esch IJP; Wijtmans M; Leurs R
    J Am Chem Soc; 2018 Mar; 140(12):4232-4243. PubMed ID: 29470065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of seven human histamine H
    Gao M; Dekker ME; Leurs R; Vischer HF
    Eur J Pharmacol; 2024 Apr; 968():176450. PubMed ID: 38387718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SAR exploration of the non-imidazole histamine H
    Wágner G; Mocking TAM; Ma X; Slynko I; Da Costa Pereira D; Breeuwer R; Rood NJN; van der Horst C; Vischer HF; de Graaf C; de Esch IJP; Wijtmans M; Leurs R
    Arch Pharm (Weinheim); 2023 Jan; 356(1):e2200451. PubMed ID: 36310109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of ZEL-H16 as a novel agonist of the histamine H3 receptor.
    Shi Y; Sheng R; Zhong T; Xu Y; Chen X; Yang D; Sun Y; Yang F; Hu Y; Zhou N
    PLoS One; 2012; 7(8):e42185. PubMed ID: 22870296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel steroidal histamine H
    Ledneczki I; Tapolcsányi P; Gábor E; Éles J; Greiner I; Schmidt É; Némethy Z; Kedves RS; Balázs O; Román V; Lévay G; Mahó S
    Bioorg Med Chem Lett; 2017 Oct; 27(19):4525-4530. PubMed ID: 28888822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-[2-(1-Cyclobutylpiperidin-4-yloxy)-6,7-dihydro-4H-thiazolo[5,4-c]pyridin-5-yl]propan-1-one: a Histamine H
    Shinde AK; Badange RK; Reballi V; Achanta PK; Bojja K; Manchineella S; Rao Muddana N; Subramanian R; Choudary Palacharla R; Benade V; Jayarajan P; Thentu JB; Lingavarapu BB; Yarra S; Kagita N; Rao Doguparthi M; Mohammed AR; Nirogi R
    ChemMedChem; 2022 Feb; 17(3):e202100583. PubMed ID: 34761873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel lead in the group of N-substituted piperazine ether derivatives with potential histamine H3 receptor activity.
    Kuder KJ; Stachnik M; Schunack W; Szymańska E; Kieć-Kononowicz K
    Med Chem; 2014; 10(6):588-99. PubMed ID: 24047214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new potent and selective histamine H3 receptor agonist, 4-(1H-imidazol-4-ylmethyl)piperidine.
    Vollinga RC; de Koning JP; Jansen FP; Leurs R; Menge WM; Timmerman H
    J Med Chem; 1994 Feb; 37(3):332-3. PubMed ID: 8308858
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and functional characterization of imbutamine analogs as histamine H3 and H4 receptor ligands.
    Geyer R; Kaske M; Baumeister P; Buschauer A
    Arch Pharm (Weinheim); 2014 Feb; 347(2):77-88. PubMed ID: 24493592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.
    Lim HD; van Rijn RM; Ling P; Bakker RA; Thurmond RL; Leurs R
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1310-21. PubMed ID: 15947036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-benzyl-1H-imidazoles with oxazoline termini as histamine H3 receptor agonists.
    Wijtmans M; Celanire S; Snip E; Gillard MR; Gelens E; Collart PP; Venhuis BJ; Christophe B; Hulscher S; van der Goot H; Lebon F; Timmerman H; Bakker RA; Lallemand BI; Leurs R; Talaga PE; de Esch IJ
    J Med Chem; 2008 May; 51(10):2944-53. PubMed ID: 18433114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histamine H3 receptor agonists.
    De Esch IJ; Belzar KJ
    Mini Rev Med Chem; 2004 Nov; 4(9):955-63. PubMed ID: 15544556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro pharmacology of a series of new chiral histamine H3-receptor ligands: 2-(R and S)-Amino-3-(1H-imidazol-4(5)-yl)propyl ether derivatives.
    Kovalainen JT; Christiaans JA; Kotisaari S; Laitinen JT; Männistö PT; Tuomisto L; Gynther J
    J Med Chem; 1999 Apr; 42(7):1193-202. PubMed ID: 10197963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971.
    Hey JA; Aslanian R; Bolser DC; Chapman RW; Egan RW; Rizzo CA; Shih NY; Fernandez X; McLeod RL; West R; Kreutner W
    Arzneimittelforschung; 1998 Sep; 48(9):881-8. PubMed ID: 9793613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoform-Specific Biased Agonism of Histamine H3 Receptor Agonists.
    Riddy DM; Cook AE; Diepenhorst NA; Bosnyak S; Brady R; Mannoury la Cour C; Mocaer E; Summers RJ; Charman WN; Sexton PM; Christopoulos A; Langmead CJ
    Mol Pharmacol; 2017 Feb; 91(2):87-99. PubMed ID: 27864425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of transmembrane helix 5 in agonist binding to the human H3 receptor.
    Uveges AJ; Kowal D; Zhang Y; Spangler TB; Dunlop J; Semus S; Jones PG
    J Pharmacol Exp Ther; 2002 May; 301(2):451-8. PubMed ID: 11961043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclopropane-based conformational restriction of histamine. (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a highly selective agonist for the histamine H3 receptor, having a cis-cyclopropane structure.
    Kazuta Y; Hirano K; Natsume K; Yamada S; Kimura R; Matsumoto S; Furuichi K; Matsuda A; Shuto S
    J Med Chem; 2003 May; 46(10):1980-8. PubMed ID: 12723960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel and highly potent histamine H3 receptor ligands. Part 2: exploring the cyclohexylamine-based series.
    Labeeuw O; Levoin N; Poupardin-Olivier O; Calmels T; Ligneau X; Berrebi-Bertrand I; Robert P; Lecomte JM; Schwartz JC; Capet M
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5384-8. PubMed ID: 21783360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.